Single Gene Analysis
General Information
- Lab Name
- Single Gene Analysis
- Lab Code
- SGN
- Epic Ordering
- SINGLE GENE ANALYSIS
- Description
This test is for a single gene selected from the BROCA, ColoSeq™, and Megalencephaly panels, which must be clearly indicated in the space provided on the requisition. Additional single gene testing can be ordered via UW OncoPlex Single Gene [OPG].
For the complete list of genes, see the following pages:
- BROCA Cancer Risk Panel [BROCA]
- ColoSeq - Lynch and Polyposis Panel [COSEQ]
- Megalencephaly Panel [MEGPX]
This test uses next-generation sequencing to detect most mutations in the gene tested. Mutations in these genes are associated with hereditary cancer risk and megalencephaly syndromes. The assay completely sequences all exons, non-repetitive introns, and flanking regions of these genes AND detects large deletions and duplications.
- References
- Pritchard CC, et al. ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 2012, 14:357-66. 22658618
- Walsh T, et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A 2010, 107:12629-33. 20616022
- Nord AS, Lee M, King MC, and Walsh T. Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics 2011, 12:184. 21486468
- Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010, 11:31-46. 19997069
- Forms & Requisitions
Requisition Form and Ordering Instructions
1. Fill out a Genetics Requisition Form
Providers with access to the UW implementation of Epic (i.e., FHCC, HMC, SCCA, UWMC, UWNW) may order this test using the order "UW Genetics and Solid Tumor Test Request."
2. Check "Single Gene Analysis"
3. Indicate specific gene/genes desired in the space provided
Genetics Preauthorization Form (preauthorization is only done for providers who are external to the UW system)
- Synonyms
- ABCC9, Adenomatous polyposis, AKT1, AKT2, AKT3, APC, ATM, ATR, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, breast cancer, BRIP1, BRWD3, CCND2, CDH1, CDK4, CDKN1C, CDKN2A, CHD8, CHEK2, Colon cancer, Cowden, CTNNA1, CTNNB1, DEPDC5, DICER1, DNMT3A, EED, EPCAM, EZH2, familial adenomatous polyposis, FANCM, FAP, FH, FLCN, GALNT12, GEN1, GLI3, GNAQ, GNAS, GPC3, GREM1, HDGC, hereditary diffuse gastric cancer, Hereditary nonpolyposis colorectal cancer, Hereditary paraganglioma, Hereditary pheochromocytoma, hereditary prostate, HNPCC, HOXB13, KCNJ8, Li-Fraumeni, Lynch Syndrome, MED12, megalencephaly, MEN1, MET, MITF, MLH1, MLH3, MSH2, MSH3, MSH6, MTOR, MUTYH, NBN, Next-generation sequencing, NF1, NF2, NPRL2, NPRL3, NSD1, NTHL1, PALB2, Peutz-Jeghers, PHOX2B, PIK3CA, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD51B, RAD51C, RAD51D, RB1, RECQL, RET, RNF135, RNF43, RPS20, SDHA, SDHB, SDHC, SDHD, SETD2, SMAD4, SMARCA4, STK11, Succinate dehydrogenase, TP53, TSC1, TSC2, VHL, Von Hippel Lindau
- Components
-
Code Name SGNGS Single Gene Analyzed SGNRE Single Gene Result SGNIN Single Gene Interpretation SGNCH Single Gene Clinical History SGNMT Single Gene Methods
Interpretation
- Method
Next-generation sequencing.
Sequences are aligned to the human genome reference (hg19). Test performed by targeted capture for listed genes followed by next-generation sequencing with Illumina technology. This test was developed and its performance characteristics determined by the University of Washington Department of Laboratory Medicine. It has not been cleared or approved by the US Food and Drug Administration. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.
- Reference Range
- See individual components
- Ref. Range Notes
No mutations detected.
- References
- Pritchard CC, et al. ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 2012, 14:357-66. 22658618
- Walsh T, et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A 2010, 107:12629-33. 20616022
- Nord AS, Lee M, King MC, and Walsh T. Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics 2011, 12:184. 21486468
- Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010, 11:31-46. 19997069
- Guidelines
Ordering & Collection
- Specimen Type
- Peripheral Blood, saliva, or purified DNA from peripheral blood or saliva ONLY. For other sample types, including cultured cells such as fibroblasts or amniocytes, please order Oncoplex Single gene testing (OPG).
- Collection
-
BLOOD:
Preferred: 10 mL whole blood in LAVENDER TOP EDTA tube.
Also acceptable: YELLOW TOP ACD tube, purified DNA from peripheral blood or cultured cells.SALIVA:
Contact laboratory for validated collection kit. - Forms & Requisitions
Requisition Form and Ordering Instructions
1. Fill out a Genetics Requisition Form
Providers with access to the UW implementation of Epic (i.e., FHCC, HMC, SCCA, UWMC, UWNW) may order this test using the order "UW Genetics and Solid Tumor Test Request."
2. Check "Single Gene Analysis"
3. Indicate specific gene/genes desired in the space provided
Genetics Preauthorization Form (preauthorization is only done for providers who are external to the UW system)
- Handling Instructions
Ship specimen at room temperature for overnight delivery.
Blood specimens can be held for up to 7 days before shipping if refrigerated.
Ship specimens to:
UW MEDICAL CENTER
LABORATORY MEDICINE - GENETICS LAB
1959 NE PACIFIC ST, ROOM NW220
SEATTLE, WA 98195-7110
- Quantity
-
requested: entire sample
minimum: 5 mL whole blood
Processing
- Processing
Blood: Refrigerate whole blood
Unacceptable Conditions: Frozen or clotted specimens
Stability (collection to initiation of testing): Ambient: 5 days; Refrigerated: 7 days; Frozen: Unacceptable
Purified DNA: Refrigerate DNA specimens. Frozen is acceptable.
Saliva:
Contact laboratory for validated collection kit.
Performance
- LIS Dept Code
- Genetics (GEN)
- Performing Location(s)
-
UW-MT Genetics Attention: Genetics Lab
Clinical lab, Room NW220
University of Washington Medical Center
1959 NE Pacific Street
Seattle, WA 98195Tel: 206-598–6429 M–F (7:30 AM–4:00 PM)
Fax: 206-616-4584
Lab email: cgateam@uw.eduTel (EXOME only): 206-543-0459
Faculty
Jillian Buchan, PhD, FACMG
Runjun Kumar, MD, PhD
Regina Kwon, MD, MPH
Christina Lockwood, PhD, DABCC, DABMGG
Brian Shirts, MD, PhD
Abbye McEwen, MD, PhD
Colin Pritchard, MD, PhD
Vera Paulson, MD, PhD
Eric Konnick, MD, MS
He Fang, PhD - Frequency
- Typical Turnaround: 3 weeks *Turn around times may vary based on factors such as tissue acquisition and insurance preauthorization.
- Available STAT?
- No
Billing & Coding
- CPT codes
- Billing Comments
For additional test/billing information, see following page: Single Gene CPT codes.
For pricing information, contact Client Support Services 206-520-4600 or 800-713-5198.
Billing and Insurance Pre-Authorization
We offer insurance pre-authorization services (preauthorization is only done for providers who are external to the UW system).
Email: gpab@uw.edu or call 1-855-320-4869 for more information.
- LOINC
- 35474-6
- Interfaced Order Code
- UOW2819